Platinum Accumulation in Pigmented Granules of Cisplatin-Treated Melanoma Cells

顺铂处理的黑色素瘤细胞色素颗粒中铂的积累

基本信息

项目摘要

To help elucidate the mechanisms for cisplatin drug resistance in the treatment of melanoma, experiments have been performed on cultured MTN-1 melanoma cells to determine changes in melanosome ultrastructure that occur with cisplatin treatment. Measurements have also been made to determine subcellular uptake of elemental platinum. Specimens were prepared by high-pressure freezing, low-temperature freeze-substitution in acetone and low-temperature embedding in UV-polymerized Lowicryl HM20 resin or in LR White resin. Sections cut to a thickness of 300 nm were stained with uranyl acetate and lead citrate, and imaged with a transmission electron microscope operating at 120 kV accelerating voltage, equipped with an energy filter. Unstained sections were also analyzed to determine the melanosomes stages according to the intensity of melanin pigments, because the melanosomes are easily visible in these preparations. To determine numbers of melanosomes, cross sections of representative whole cells were obtained by montaging, and melanosomes were counted. Unstained ultramicrotomed sections were imaged by TEM and analyzed using electron probe x-ray microanalysis in a scanning transmission electron microscope, equipped with a field-emission source. Sections were also analyzed using the x-ray microprobe situated on beamline 2-ID-D of the Advanced Photon Source at Argonne National Laboratory. The x-ray microprobe provides increased sensitivity for platinum detection due to its high brightness synchrotron source but gives lower spatial resolution due to limits of the zone-plate x-ray optics. Results from these complementary approaches showed that prolonged treatment with cisplatin increased the number of intracellular pigmented granules (melanosomes), and importantly revealed accumulation of platinum in the melanosomes. The findings provide evidence that melanosomes contribute to the refractory properties of melanoma cells by sequestering cytotoxic drugs and increasing melanosome mediated drug export. Preventing melanosomal sequestration of cytotoxic drugs by inhibiting the functions of melanosomes or disrupting melanosomal structures might offer a potential approach for enhancing the chemosensitivity of melanoma cells. Experiments are being conducted to test these therapeutic approaches by studying ultrastructure changes in the electron microscope and by measuring differences in cisplatin uptake using the synchrotron-based x-ray microprobe.
为了帮助阐明顺铂在黑色素瘤治疗中的耐药机制,我们在培养的MTN-1黑色素瘤细胞上进行了实验,以确定顺铂治疗后黑色素小体超微结构的变化。测量也被用来确定元素铂的亚细胞摄取。采用高压冷冻、低温丙酮冷冻取代、低温包埋于uv聚合的Lowicryl HM20树脂或LR White树脂中制备样品。切成300 nm厚度的切片,用醋酸铀酰和柠檬酸铅染色,在120 kV加速电压下,安装能量过滤器,用透射电子显微镜成像。我们还分析了未染色的切片,根据黑色素的强度来确定黑素小体的分期,因为黑素小体在这些制剂中很容易看到。为了确定黑素体的数量,采用蒙太奇法获得代表性全细胞的横截面,并对黑素体进行计数。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Leapman其他文献

Richard Leapman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Leapman', 18)}}的其他基金

Structure Of Beta Amyloid Fibrils
β淀粉样原纤维的结构
  • 批准号:
    7967868
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Development of Conjugated Gold Clusters for Studies on Cellular Internalization
用于细胞内化研究的共轭金簇的开发
  • 批准号:
    8933888
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Mass Mapping of Macromolecular Assemblies
大分子组装体的质量作图
  • 批准号:
    8743765
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Energy-Filtered Electron Tomography
能量过滤电子断层扫描
  • 批准号:
    8743771
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Electron microscopy of therapeutic and diagnostic nanoparticles
治疗和诊断纳米颗粒的电子显微镜
  • 批准号:
    9152063
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Ultrastructure of a Carbon Nanotube-based Delivery System for Cancer Therapy
用于癌症治疗的碳纳米管输送系统的超微结构
  • 批准号:
    8340620
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Intramural Training of NIH Biomedical Imaging and Bioengineering Researchers
NIH 生物医学成像和生物工程研究人员的校内培训
  • 批准号:
    8340644
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM
通过串行块面 SEM 进行三维细胞和组织重建
  • 批准号:
    9361491
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Energy-Filtered Electron Microscopy and Electron Spectroscopic Imaging
能量过滤电子显微镜和电子光谱成像
  • 批准号:
    10011332
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:
Mass Mapping of Macromolecular Assemblies
大分子组装体的质量作图
  • 批准号:
    7593811
  • 财政年份:
  • 资助金额:
    $ 2.38万
  • 项目类别:

相似海外基金

Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 2.38万
  • 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
  • 批准号:
    16K11932
  • 财政年份:
    2016
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
  • 批准号:
    19591274
  • 财政年份:
    2007
  • 资助金额:
    $ 2.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
  • 批准号:
    6346309
  • 财政年份:
    2000
  • 资助金额:
    $ 2.38万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    2720213
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    6513197
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    7101017
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    6894842
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    2885074
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    6174221
  • 财政年份:
    1999
  • 资助金额:
    $ 2.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了